Paper41746978
Analysis and comparison of the trends in the burden of motor neuron disease in China and worldwide from 1990 to 2021.
Fu Y and 4 others. PLoS One, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Analysis and comparison of the trends in the burden of motor neuron disease in China and worldwide from 1990 to 2021. Papers, record 41746978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41746978
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analysis and comparison of the trends in the burden of motor neuron disease in China and worldwide from 1990 to 2021.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Motor Neuron Disease | Major topic |
| China | |
| Female | |
| Disability-Adjusted Life Years | |
| Male | |
| Humans | |
| Global Burden of Disease | |
| Incidence | |
| Prevalence | |
| Middle Aged | |
| Aged |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40201583 | Global, regional, and National Burden of chronic kidney disease attributable to dietary risks from 1990 to 2021. | Front Nutr | 2025 | https://conductscience.org/library/papers/40201583 | PubMed |
| 2 | 36159285 | Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019. | Front Public Health | 2022 | https://conductscience.org/library/papers/36159285 | PubMed |
| 3 | 34699945 | China amyotrophic lateral sclerosis registry of patients with Traditional Chinese Medicine (CARE-TCM): Rationale and design. | J Ethnopharmacol | 2022 | https://conductscience.org/library/papers/34699945 | PubMed |
| 4 | 39343443 | New developments in the diagnosis and management of motor neuron disease. | Br Med Bull | 2024 | https://conductscience.org/library/papers/39343443 | PubMed |
| 5 | 26347879 | Motor Neuron Diseases in Sub-Saharan Africa: The Need for More Population-Based Studies. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26347879 | PubMed |
| 6 | 37450244 | The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy. | Mol Neurobiol | 2023 | https://conductscience.org/library/papers/37450244 | PubMed |
| 7 | 32888367 | Incidence of motor neuron disease/amyotrophic lateral sclerosis in South Africa: a 4-year prospective study. | Eur J Neurol | 2021 | https://conductscience.org/library/papers/32888367 | PubMed |
| 8 | 30409709 | Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. | Lancet Neurol | 2018 | https://conductscience.org/library/papers/30409709 | PubMed |
| 9 | 34229639 | Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis. | BMC Public Health | 2021 | https://conductscience.org/library/papers/34229639 | PubMed |
| 10 | 38642570 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. | Lancet | 2024 | https://conductscience.org/library/papers/38642570 | PubMed |
| 11 | 34873335 | Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. | Nat Genet | 2021 | https://conductscience.org/library/papers/34873335 | PubMed |
| 12 | 40905633 | Targeting Amyotrophic Lateral Sclerosis with Gene Therapy: From Silencing Genes to Enhancing Neuroprotection. | Hum Gene Ther | 2025 | https://conductscience.org/library/papers/40905633 | PubMed |
| 13 | 40772655 | Amyotrophic lateral sclerosis in Mainland China: clinical translational challenges and opportunities. | Curr Opin Neurol | 2025 | https://conductscience.org/library/papers/40772655 | PubMed |
| 14 | 41103971 | Rethinking ALS: Current understanding and emerging therapeutic strategies. | AIMS Neurosci | 2025 | https://conductscience.org/library/papers/41103971 | PubMed |
| 15 | 38354985 | Sex biology in amyotrophic lateral sclerosis. | Ageing Res Rev | 2024 | https://conductscience.org/library/papers/38354985 | PubMed |
| 16 | 34288593 | Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. | Cancer Commun (Lond) | 2021 | https://conductscience.org/library/papers/34288593 | PubMed |
| 17 | 39449162 | Prognostic Value of Systemic Inflammation, Nutritional Status and Sarcopenia in Patients With Amyotrophic Lateral Sclerosis. | J Cachexia Sarcopenia Muscle | 2024 | https://conductscience.org/library/papers/39449162 | PubMed |
| 18 | 38898231 | Gene therapy for CNS disorders: modalities, delivery and translational challenges. | Nat Rev Neurosci | 2024 | https://conductscience.org/library/papers/38898231 | PubMed |
| 19 | 37511491 | Frontotemporal Dementia, Where Do We Stand? A Narrative Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37511491 | PubMed |
| 20 | 35614235 | Curing SMA: Are we there yet? | Gene Ther | 2023 | https://conductscience.org/library/papers/35614235 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C9orf72 | 203228 | PubTator's text mining | https://conductscience.org/library/genes/203228 | NCBI Gene |
| ERLIN1 | 10613 | PubTator's text mining | https://conductscience.org/library/genes/10613 | NCBI Gene |
| KIF5A | 3798 | PubTator's text mining | https://conductscience.org/library/genes/3798 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41746978
GET https://conductscience.org/api/papers/v1/41746978/references?page=2